Divis Laboratories Ltd reported INR29.99B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Alaunos Therapeutics USD 2K 0 Jun/2025
Aurobindo Pharma INR 75.94B 16.86B Mar/2026
Avita Medical AUD 9.11M 2.26M Dec/2025
Dianthus Therapeutics USD 52K 4.95M Dec/2025
Divis Laboratories Ltd INR 29.99B 3.71B Mar/2026
Ionis Pharmaceuticals USD 74M 8M Mar/2026
IQVIA Holdings USD 3.38B 52M Mar/2026
Lupin INR 66.6B 2.85B Mar/2026
Moderna USD 71M 113M Mar/2026
Organon & Co USD 1.33B 153M Dec/2025
Revvity USD 691.38M 53.29M Mar/2026
Tectonic Therapeutic USD 0 270K Dec/2023
Tilray USD 109.07M 2M Sep/2025
Viatris USD 3.08B 45M Mar/2026
Xeris Pharmaceuticals USD 51.05M 2.7M Dec/2025